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(ROS) generation, cell fragility and membrane exovesiculation
were measured in RBCs throughout the storage period, with or
without stimulation by oxidants, supplementation of N-
acetylcysteine and energy depletion, following incubation of
stored cells for 24 h at 37 °C. Apart from cell characteristics, the
total or uric acid-dependent antioxidant capacity of the super-
natant in addition to extracellular potassium concentration was
determined in RBC units. Finally, procoagulant activity and protein
carbonylation levels were measured in the microparticles popu-
lation. Further information can be found in “Glucose 6-phosphate
dehydrogenase deﬁcient subjects may be better “storers” than
donors of red blood cells” [1].
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology
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ow data was
acquiredCell fragility tests, hemolysis and total antioxidant capacity were measured
spectrophotometrically. Reactive oxygen species were quantiﬁed by ﬂuoro-
metry. Supernatant potassium and microparticles were assayed using Elecsys
Systems Analyzer (Roche) and ﬂow cytometry, respectively. Microparticles’
pro-coagulant activity and protein carbonylation were measured by Elisa
assays. Metabolomics analysis was performed by ultimate high pressure
liquid chromatography-mass spectrometry coupled online with a Q Exactive
system.ata format Analyzed
xperimental
factorsIntracellular ROS generation was measured in energy depleted stored RBCs
(incubation for 24 h at 37 °C). Osmotic and mechanical fragility indexes were
estimated in situ or after incubation of stored RBCs at the same conditions
(24 h/37 °C). Apart from microparticles’ and metabolomics analysis, all other
assays were performed on day 42 samples with or without supplementation
of the units with 2.5 mM N-acetylcysteine (NAC).xperimental
featuresPhysiological characteristics of stored RBCs and supernatants and malate
variation were examined in RBC units donated by G6PD and G6PDþ eligible
donors. Most measurements were performed at week intervals of the storage
period. NAC supplementation was applied to aliquots of the RBC units on day
21 of storage and the effects were analyzed on day 42 samples.ata source
locationNational and Kapodistrian University of Athens (NKUA), School of Science,
Athens 15784, Greece
Technological and Educational Institute of Athens, Athens 12210, Greece
University of Colorado, School of Medicine–Anschutz Medical Campus, Aur-
ora, 80045 CO, USAata accessibility Data with this articleD
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 The different storage proﬁle when additional oxidative stimuli are added, is of value for the
understanding of G6PD deﬁcient red blood cells’ physiology and its clinical relevance to the
transfusion's outcomes.
 Cell fragilities proﬁles and microparticles’ characteristics might help elucidating the storage
capacity (“storability”) of G6PD deﬁcient red blood cells.
 Our data contribute to the clariﬁcation of donor-variation and N-acetylcysteine supplementation
effects on red blood cell storage lesion1. Data
We assessed the storage quality of red blood cells (RBCs) donated by glucose-6-phosphate
dehydrogenase (G6PD) deﬁcient, yet eligible, donors compared to control (G6PD sufﬁcient) red
blood cells [1]. Intracellular reactive oxygen species (ROS) accumulation was similar in energy
depleted (24 h/37 °C) G6PD and G6PDþ stored RBCs while stimulation by tert-Butyl hydroperoxide
(tBHP) and diamide oxidants resulted in statistically signiﬁcant increase in ROS accumulation in the
G6PD group (n¼6) compared to the G6PDþ group (n¼3) (Fig. 1). RBC fragility (both mean cor-
puscular fragility, MCF and mechanical fragility index, MFI) (Fig. 2) and the characteristics of the
microparticles (accumulation, pro-coagulant activity and protein carbonylation index, PCI) (Fig. 3)
were equal between the groups under examination throughout the storage period, while only slight
differences were observed in the antioxidant capacity of the supernatant (Fig. 4).
Malate levels decreased faster in G6PD RBCs than in control, G6PDþ RBCs during the storage
period in CPD-SAGM (Fig. 5). Finally, N-acetylcysteine (NAC) supplementation (at the concentration
used) induced similar changes in both stored RBCs and supernatant (Fig. 6).2. Experimental design, materials and methods
2.1. Blood collection and processing
Blood samples from 9 regular male donors 22–30 years old (n¼6 for Mediterranean variant grade
II WHO G6PD donors and n¼3 for donors with normal levels of G6PD activity) were collected into
EDTA or citrate vacutainers. The quality of RBC concentrates prepared from the same donors was
evaluated in pre-storage leukoreduced (RC High efﬁciency leukocyte removal ﬁlters, Haemonetics,
MA, USA), citrate-phosphate-dextrose (CPD)/saline-adenine-glucose-mannitol (SAGM) units
throughout a 42 days storage in a controlled environment at 4 °C as previously described [1]. Samples
were taken after 2 days of storage and weekly thereafter or on days 21 and 42 (middle and maximal
storage duration, respectively).
2.2. Redox status estimation
ROS accumulation in stored RBCs was detected with the membrane-permeable, non-ﬂuorescent
and redox-sensitive probe 5-(and-6)-chloromethyl-20,70-dichloro-dihydro-ﬂuorescein diacetate,
acetyl ester (CM-H2DCFDA) according to the manufacturer's guidelines (Invitrogen, Molecular Probes,
Eugene, OR) with minor modiﬁcations as previously described [2]. After resuspension of RBCs at 1%
hematocrit, 10 mM of CM-H2DCFDA were added and ﬂuorescence was measured at 490 nm excitation
and 520 nm emission wavelengths by using the VersaFluor Fluorometer System (Bio-Rad, Hercules,
CA). ROS production using exogenous stimuli was calculated after incubation of RBCs with 100 mM
tert-Butyl hydroperoxide (tBHP) for 20 min at 20 °C or 2 mM diamide for 45 min at 37 °C.
The ferric reducing antioxidant power (FRAP) assay was used for the estimation of Total Anti-
oxidant Capacity (TAC) of the plasma [3]. Brieﬂy, small aliquots of plasma were mixed with freshly
prepared working FRAP solution (containing acetate buffer (pH 3.6, 300 mM), TPTZ (2,4,6-tripyridyl-
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Fig. 1. ROS generation in energy depleted G6PD-deﬁcient (G6PD n¼6) and control (G6PDþ n¼3) RBCs. RBCs stored for
variable periods of time in CPD-SAGM preservative/additive solution were incubated for 24 h at 37 °C and intracellular ROS
accumulation was estimated by ﬂuorometry with or without stimulation by oxidants (100 μM tBHP for 20 min at 20 °C and
2 mM diamide for 45 min at 37 °C). Stimulated ROS were normalized to the pre-treatment levels (dashed lines). RFU, relative
ﬂuorescence units. *Po0.05 versus control (G6PDþ) donors; data shown as mean7standard deviation.
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V.L. Tzounakas et al. / Data in Brief 8 (2016) 618–627622s-triazine, 10 mM) in HCl (40 mM) and FeCl3 (20 mM) in 10:1:1 ratio) and incubated for 4 min at 37 °C
in a water bath. Absorbance was measured at 593 nm. Uric acid-dependent and -independent anti-
oxidant capacity were determined after uricase treatment of the samples (for 20 min at 25 °C) [4].
Redox status estimation tests were also performed after N-acetylcysteine (NAC) supplementation
(2.5 mM) or incubation for 24 h at 37 °C.
2.3. Hemolysis and cellular fragility assays
Plasma free hemoglobin was calculated following a method ﬁrst described by Harboe [5]. Blood
samples were centrifuged at 1000 g for 10 min. Plasma was collected and centrifuged again under
the same conditions. Cell free supernatants were diluted in distilled water and incubated at 20 °C for
30 min. Hb absorbance was measured versus blank at 380, 415 and 450 nm. The ﬁnal OD was cal-
culated as follows: 2OD415OD380OD450.
In vitro osmotic fragility behavior of erythrocytes was determined in solutions of increasingly
saline concentration (0.0–0.9% w/v NaCl) [6]. 10 ml of blood samples were added in 1.0 ml of each
saline solution, incubated for 15 min at 20 °C and then centrifuged at 1500 rpm for 5 min. Hb released
in the supernatant was measured at 540 nm, plotted against saline concentration and the mean
corpuscular fragility (MCF), which corresponds to the saline concentration causing 50% of hemolysis,
was calculated.
Mechanical fragility of RBCs was evaluated as previously described [7]. Brieﬂy, blood from each
donor was mixed with stainless steel beads, rocked in a rocker platform for 1 h and free Hb was
measured in the plasma by using both Harboe's method against an un-rocked control. The mechanical
fragility index (MFI) was calculated using the formula:
MFI¼ Hbrocked–Hbcontrolð Þ= Hbaliquot–Hbcontrol
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Fig. 2. RBC fragilities proﬁles. Variation in mean corpuscular fragility (MCF) (A) and mechanical fragility index (MFI) (B) of
G6PD (n¼6) and control (G6PDþ) (n¼3) RBCs before (NS, non-stored) and during storage in CPD-SAGM. Left panels: MCF and
MFI measurements in situ (no treatment of RBCs). Right panels: MCF and MFI measurements following incubation of non-
stored and stored RBCs for 24 h at 37 °C (iMCF, iMFI). *Po0.05 versus control; data shown as mean7standard deviation.
Fig. 3. Microparticles characterization. Left panel: (A) Flow cytometry estimation of RBC-derived Annexin V-positive micro-
particles in control (n¼3) and G6PD (n¼6) samples before (non-stored, NS) and during the storage. (B) After normalization to
the second day of storage (dashed line) the G6PD RBCs exhibited a trend for higher microvesiculation rate compared to the
control RBCs. (C) Microparticles-associated procoagulant activity measured by Elisa was similar in the two groups under
examination. *Po0.05 versus control; data shown as mean7standard deviation. Right panel: (D) relative percentage of car-
bonylated proteins in microparticles collected from G6PDþ (individuals # 1 and 2) and G6PD (individuals # 3–5) supernatant
on the day 42 of storage and (E) representative immunoblot analysis by using anti-DNP antibody. Stomatin was used as internal
control.
V.L. Tzounakas et al. / Data in Brief 8 (2016) 618–627 623where Hbrocked is the mean free Hb concentration in the supernatants of the rocked specimens,
Hbcontrol is the average free Hb concentration in the supernatants of the control samples, and Hbaliquot
is the average Hb concentration of the RBC aliquots at a Hct of 40%. Hemolysis and cellular fragility
tests were also performed after NAC supplementation (2.5 mM) or incubation for 24 h at 37 °C.
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Fig. 4. Estimation of the antioxidant capacity in fresh plasma and supernatant collected from the stored RBC units. Total, uric
acid-dependent and uric acid-independent antioxidant capacity in G6PD (n¼6) and control (G6PDþ) (n¼3) samples in vivo
(non-stored, NS) and during storage. *Po0.05 versus control. Data is shown as mean7standard deviation.
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Fig. 6. NAC effect on physiological characteristics of stored G6PD (n¼6) and control (G6PDþ , n¼3) RBCs. Packed RBC units
were treated with 2.5 mM NAC (from day 21 to day 42) and samples were collected on the last day of storage. All data are
normalized to pre-treatment levels (dashed lines). *Po0.05 versus control. TAC, total antioxidant capacity; UA-ind AC, uric acid
independent antioxidant capacity; UA-dep AC, uric acid dependent antioxidant capacity, Sup Kþ , supernatant potassium; PS,
phosphatidylserine exposure at RBC surface; data shown as mean7standard deviation.
CONTROL
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Fig. 5. Malate variation in G6PD (n¼6) and control (G6PDþ , n¼3) RBCs during storage in CPD-SAGM. Metabolomics analysis
showed a faster decrease of malate levels in G6PD RBCs than in controls. Blue line: control; solid and dashed red lines:
medianþSD for G6PD cells.
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Enumeration and characterization of supernatant and circulating microparticles was performed by
ﬂow cytometry in aliquots of supernatant or plasma produced after two “light” spins of citrated blood
at 20 °C. Microparticles were identiﬁed by size (o1 μm), RBC origin (FITC-conjugated anti-CD235)
and PS exposure (AnnexinV-positive, AnnVþ) as previously described [8].
V.L. Tzounakas et al. / Data in Brief 8 (2016) 618–627626Microparticles-associated procoagulant activity was estimated through thrombin generation
measurement by using a functional Elisa assay kit (Zymuphen MP-activity) according to the manu-
facturers’ instructions (Hyphen BioMed, Neuville-sur-Oise, France).
Microparticles isolation by high speed centrifugation of the supernatants (37,000 g for 1 h) of
G6PD (n¼3) and control (G6PDþ) units (n¼2) on day 42 of storage and the subsequent mea-
surement of carbonylated proteins in the vesicular pellet (Oxyblot detection kit, Millipore, Temecula,
CA) were performed as previously described [2,9]. The relative membrane expression of each com-
ponent was estimated by scanning densitometry. HRP-conjugated antibodies to rabbit and to mouse
IgGs were from GE Healthcare (Buckinghamshire, UK) and DakoCytomation (Glostrup, Denmark),
respectively. Western lighting Plus ECL was from Perkin Elmer (CA, USA).
2.5. Malate estimation by metabolomics analysis
Metabolomics analyses were performed as previously reported [10,11] and extensively described
in (“Glucose 6-phosphate dehydrogenase deﬁcient subjects may be better “storers” than donors of red
blood cells”) [1].
2.6. NAC supplememtation
NAC (Sigma-Aldrich, Munich, Germany) was used in the majority of experiments as an exogenous
antioxidant factor. Brieﬂy, 2.5 mM NAC was added in RBC aliquots at the middle of storage period (day
21) and its effect was measured at the last day of storage (day 42).Acknowledgments
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